SQZ Biotechnologies Co (SQZ)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Armon Sharei
Employees:
120
200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, MA 02472
617-898-8824

SQZ Biotechnologies develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with other immuno-oncology agents. The company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 94.576 Million Shares Outstanding28.148 Million Avg 30-day Volume 61.373 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.27
Price to Revenue3.8901 Debt to Equity0.0 EBITDA-77.844 Million
Price to Book Value1.0229 Operating Margin-335.6893 Enterprise Value-15.353 Million
Current Ratio3.869 EPS Growth-3.273 Quick Ratio3.711
1 Yr BETA 1.4696 52-week High/Low 16.17 / 2.61 Profit Margin-334.8872
Operating Cash Flow Growth-11.163 Altman Z-Score-2.0194 Free Cash Flow to Firm -69.17 Million
View SEC Filings from SQZ instead.

View recent insider trading info

Funds Holding SQZ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SQZ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-07-11:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-31:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-19:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-09:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-12-02:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K/A: filed on 2021-11-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-04:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-10-26:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ZAJIC MICAH CHIEF FINANCIAL OFFICER

    • Officer
    10,000 2022-07-11 2

    KNOPF LAWRENCE J GENERAL COUNSEL

    • Officer
    1,938 2022-06-30 3

    SHAREI ARMON PRESIDENT AND CEO

    • Officer
    • Director
    287,884 2022-06-30 4

    CAPASSO RICHARD SEE REMARKS

    • Officer
    1,183 2022-06-30 3

    SCHULMAN AMY W

    • Director
    • 10% Owner
    20,000 2022-06-15 3

    VINK PATRICK V.J.J.

    • Director
    20,000 2022-06-15 1

    SRIVASTAVA SAPNA

    • Director
    20,000 2022-06-15 1

    BOLNO PAUL

    • Director
    20,000 2022-06-15 1

    SCHEGERIN MARC

    • Director
    20,000 2022-06-15 1

    COULIE BERNARD

    • Director
    20,000 2022-06-15 1

    GARG PUSHKAL

    • Director
    20,000 2022-06-15 1

    JENSEN KLAVS F.

    • Director
    20,000 2022-06-15 2

    ELIA MARC

    • Director
    20,000 2022-06-15 1

    WARREN MARSHELLE SMITH CHIEF MEDICAL OFFICER

    • Officer
    200,000 2022-06-01 2

    BERNSTEIN HOWARD PHD MD CHIEF SCIENTIFIC OFFICER

    • Officer
    195,000 2022-02-10 1

    FIRST DAVID CHIEF PEOPLE OFFICER

    • Officer
    66,000 2022-02-10 1

    ROSEN OLIVER CHIEF MEDICAL OFFICER

    • Officer
    75,625 2021-02-23 0

    LOXAM TERI CHIEF FINANCIAL OFFICER

    • Officer
    75,950 2021-02-23 0

    AMERICAN INTERNATIONAL GROUP INC

    • 10% Owner
    No longer subject to file 2020-11-03 0

    TEMASEK HOLDINGS (PRIVATE) LTD

    • 10% Owner
    4,402,848 2020-11-03 0

    INVUS PUBLIC EQUITIES, L.P.

    MINNE PASCAL

    ARTAL INTERNATIONAL S.C.A.

    ARTAL INTERNATIONAL MANAGEMENT S.A.

    ARTAL GROUP S.A.

    WESTEND S.A.

    STICHTING ADMINISTRATIEKANTOOR WESTEND

    ARTAL TREASURY LTD

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    • 10% Owner
    No longer subject to file 2020-11-03 0

    POLARIS MANAGEMENT CO. VII, L.L.C.

    POLARIS ENTREPRENEURS' FUND VII, L.P.

    POLARIS PARTNERS VII, L.P.

    • 10% Owner
    2,727,646 2020-11-03 0

    AMY SCHULMAN, AS TRUSTEE THE ARMON R. SHAREI IRREVOCABLE GST TRUST OF 2016, U/D/T DATED DECEMBER 29, 2016

    • 10% Owner
    No longer subject to file 2020-11-03 0

    LANGER ROBERT

    • 10% Owner
    243,987 2020-10-29 0

    MOESSLINGER ERIC

    • Director
    0 2020-10-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ZAJIC MICAH - Officer CHIEF FINANCIAL OFFICER

    2022-07-13 17:00:17 -0400 2022-07-11 A 10,000 a 10,000 direct

    SHAREI ARMON - Director - Officer PRESIDENT AND CEO

    2022-07-05 13:00:53 -0400 2022-06-30 A 2,436 $2.70 a 287,884 direct 1.8987 4.1139 10.1266 4 0.0 1

    CAPASSO RICHARD - Officer SEE REMARKS

    2022-07-05 13:00:24 -0400 2022-06-30 A 1,183 $2.70 a 1,183 direct 1.8987 4.1139 10.1266 4 0.0 1

    KNOPF LAWRENCE J - Officer GENERAL COUNSEL

    2022-07-05 13:00:34 -0400 2022-06-30 A 1,484 $2.70 a 1,938 direct 1.8987 4.1139 10.1266 4 0.0 1

    SCHULMAN AMY W - Director - > 10% Owner

    2022-06-16 17:01:28 -0400 2022-06-15 A 20,000 a 20,000 direct

    GARG PUSHKAL - Director

    2022-06-16 17:01:07 -0400 2022-06-15 A 20,000 a 20,000 direct

    BOLNO PAUL - Director

    2022-06-16 17:00:59 -0400 2022-06-15 A 20,000 a 20,000 direct

    VINK PATRICK V.J.J. - Director

    2022-06-16 17:00:50 -0400 2022-06-15 A 20,000 a 20,000 direct

    SRIVASTAVA SAPNA - Director

    2022-06-16 17:00:40 -0400 2022-06-15 A 20,000 a 20,000 direct

    JENSEN KLAVS F. - Director

    2022-06-16 17:00:36 -0400 2022-06-15 A 20,000 a 20,000 direct

    SCHEGERIN MARC - Director

    2022-06-16 17:00:29 -0400 2022-06-15 A 20,000 a 20,000 direct

    COULIE BERNARD - Director

    2022-06-16 17:00:22 -0400 2022-06-15 A 20,000 a 20,000 direct

    ELIA MARC - Director

    2022-06-16 17:00:19 -0400 2022-06-15 A 20,000 a 20,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 22:15:03 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 21:45:04 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 21:15:03 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 20:45:04 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 20:15:03 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 19:45:04 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 19:15:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 18:45:03 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 18:15:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 17:45:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 17:15:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 16:45:04 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 16:15:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 15:45:05 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 15:15:03 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 14:45:06 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 14:15:04 UTC -0.9514 3.2714 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 13:45:04 UTC 0.7882 1.5318 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 13:15:04 UTC 0.7882 1.5318 1000000
    SQZ BIOTECHNOLOGIES CO SQZ 2022-08-11 12:45:04 UTC 0.7882 1.5318 1000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund SQZ -1805.0 shares, $-6660.45 2022-04-30 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund SQZ -12812.0 shares, $-61625.72 2022-03-31 N-PORT

    Elevate your investments